Emcure Pharma Q4 FY26 Earnings Call on May 5, 2026

Board & Shareholder Meetings View source PDF

EMCURE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+5.3%1-day move

₹1610.00

prior close

₹1660.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.2+0.2+1.5+4.1+5.3+11.7+4.9+3.7+2.9+4.0+8.8+6.5+14.4—

Up moveDown movePending

AI summary

Emcure Pharmaceuticals has scheduled an earnings call for investors and analysts on Tuesday, May 5, 2026 at 3:30 PM IST to discuss its audited financial results (standalone and consolidated) for Q4 and full year ended March 31, 2026. International dial-in numbers are provided for India, Hong Kong, Singapore, UK, and USA. The transcript and audio recording will be made available on the company's website afterward.

Likely market impact

Investors will gain insight into Q4 and FY26 full-year performance. Watch for management commentary on growth, margins, and FY27 outlook.